Remote Patient Monitoring & Connected Devices

A global leader in infectious disease therapeutics engaged Health Advances to create a refined and detailed development plan for a connected drug delivery solution strategy and relevant assets. The team leveraged past primary research conducted with physicians, payers, and industry experts as well as analysis of analogs to create a cohesive document for the client's internal organization on target product profiles, feature prioritization, go-to-market strategy, required investments and future governance structure. These materials were refined with the help of the client's internal team to secure funding from senior leadership for solution development initiation and begin vendor RFP processes.

As it prepared to launch a first-to-market connected device, a global medical device company approached Health Advances to share its insights on potential market access and reimbursement opportunities for the company. Health Advances drafted a memorandum to share insights from our prior work in this field, augmented by targeted new secondary research. Each pathway described, which included NTAP, TPT, and breakthrough device, among others, gave an overview, delineated benefits/opportunities, risks/challenges, implications for client, and likelihood of success. The summary outlined the most likely reimbursement and payment scenarios, which were currently available, to ensure the client could maximize both the near- and long-term value of this product. 

Health Advances was engaged by a large medical device company to evaluate the most attractive strategy and business model to commercialize a connected home device for the prevention of chronic wounds. Through significant secondary and primary research, the team assessed the clinical demand for the product, the current and future willingness for various payer types to reimburse the preventative product, and the attractiveness of several business models. All analyses supported a revenue forecast for multiple versions of the product with different business models to help our client determine an appropriate investment decision.

On behalf of an orthopedic device manufacturer, Health Advances assessed the potential for connected orthopedic implants to secure reimbursement for remote patient monitoring performed by physician users. The team interviewed medical directors at a variety of plan types and several regulatory experts to understand both overall receptivity to reimbursing remote patient monitoring associated with an implant and the likely evidence generation requirements to support broad coverage going forward. Ultimately the research helped the client understand the potential for provider reimbursement as an input to its overall development and commercialization strategy.